Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

China Names 48 Critical Foreign Drugs To Expedite Approvals

By Catherine Sbeglia | August 13, 2018

In a move consistent with policy changes in China to ease up on drug approval regulations, the country’s Center for Drug Evaluation (CDE) released a list of 48 drugs—already approved outside of China—that it hopes to make eligible for expedited clearance. The drugs, most of which are treatments for rare diseases or for the prevention and treatment of life-threatening diseases, have been deemed clinically urgent.

The drugs targeted by the CDE include Merck’s anti-PD-1 therapy Keytruda and Amgen’s cholesterol therapy Repatha, and Gilead Sciences HIV therapy Genvoya.

Because speedy clearance is a priority, the CDE is focusing its efforts on drugs approved in Europe, Japan, or the U.S. that won’t require additional studies to be conducted in China. Instead, true to an announcement made last year, China says companies can submit the drugs for regulatory approval using data from overseas markets if it is believed there are no safety or efficacy differences across ethnicities.

(Source: The Wall Street Journal; Bloomberg)

Related Articles Read More >

Doctor, woman patient and tablet for consulting with results, medical info and talk for healthcare with mockup space. Japanese medic, digital touchscreen or show video for surgery, wellness or advice.
Putting patients first in clinical trials
Confidently navigate the transition from bench to batch
Merck
FDA approves Merck’s Winrevair to treat pulmonary arterial hypertension
kobayashi pharmaceutical logo
Report: Japan health authorities investigate Kobayashi Pharmaceutical factory after five deaths
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE